Designing the company's clinical research development strategy, conducting clinical studies, searching for research gaps, developing study budgets, identifying potential risks, heading the clinical team, writing grant proposals, guidelines, and scientific articles, attending conferences, developing contacts with KOLs, collaborating with Scientific Advisory Boards formed by world-class scientists, gathering competitive intelligence, conducting medical education activities and preparing scientific presentations for students, clinicians, and investors, supporting healthcare professionals with continuous training, and establishing cooperation with new hospitals and universities clinics.Key achievements: The company's clinical development strategy, creating a clinical team and Scientific Advisory Board from scratch, developing contacts with 54 KOLs, heading the clinical team, and managing 11 international studies. The publication of three scientific research articles.

1. Management of a scientific project related to the optimization of the synthesis pathway of potential GABA-A receptor ligands. The research was founded by the Ministry of Science and Higher Education (grant No. N42/DBS/000186).Key achievements: Acquisition of grant, Optimization of the preparation of the drug (zolpidem) from 33h to 2.5h, development of the best method to obtain a salt with good bioavailability and solubility

Structure-activity relationship analysis and synthesis of structurally diverse nitrogenous heterocyclic potential selective α1-GABA-A receptor ligands (grant No. 2018/30/E/NZ7/00247).Key achievements: Obtaining 60 ligands, detailed structure-activity analysis,2 articles, patent application.

Management of a scientific project related to the design and synthesis of hybrid ligands: combining H2S donor activity and GABA-A receptor affinity with potential neuroprotective activity. The research was founded by the Ministry of Science and Higher Education (grant No. N42/DBS/000055).Key achievements: Acquisition of grant, obtaining ligands with neuroprotective effects

Supporting the development of Azoty Group in the field of academic community, organization of scientific events, creation and implementation of projects.

Application of in vivo Raman spectroscopy for chemical characterization of tissues affected by civilization diseases (No. 2015/ 17/B/ST4/03894).Key achievements: evaluation of lung fragments by Raman spectroscopy

Literature analysis and planning of synthetic pathways, synthesis and purification of reaction mixtures, LCMS and NMR analysis.